Join the Accutane group to help and get support from people like you.
Accutane News
2004 to 2019 Saw Increase in Isotretinoin Use in Girls, Women
THURSDAY, Jan. 25, 2024 – From 2004 to 2019, there was an increase in isotretinoin use among girls and women of childbearing age in Germany, according to a study published online Jan. 25 in PLOS...
No Increased Suicide Risk Observed for Isotretinoin Users
MONDAY, Dec. 4, 2023 – Isotretinoin users do not have an increased risk for suicide or psychiatric disorders and may have a lower risk for suicide attempts, according to a review published online...
One Drug Clear Winner in Treating Acne: Review
MONDAY, July 31, 2023 – Millions of people live with acne, and it can take a dramatic toll on their quality of life, but is any one treatment better than the rest? Yes, suggests a new review of more t...
Review: Oral Isotretinoin Is the Best Treatment for Acne
THURSDAY, July 27, 2023 – The most effective treatment for acne is oral isotretinoin, according to a review published in the July/August issue of the Annals of Family Medicine. Chung-Yen Huang,...
FDA Medwatch Alert: Accutane (isotretinoin) - Nov 1, 2002
FDA and Roche revised the WARNINGS: Psychiatric Disorders, Boxed CONTRAINDICATIONS AND WARNINGS, DOSAGE AND ADMINISTRATION, and PRECAUTIONS: Drug Interactions sections of the prescribing information....
FDA Medwatch Alert: Accutane (isotretinoin) - Mar 28, 2007
[Posted 03/28/2007] FDA notified consumers and healthcare professionals of a special webpage launched to warn about the dangers of buying isotretinoin online. Isotretinoin is a drug approved for the...
FDA Medwatch Alert: Isotretinoin - Accutane and generic isotretinoin - Oct 6, 2006
[Posted 10/06/2006] FDA and the iPLEDGE program notified healthcare professionals and patients of an update to iPLEDGE, a risk management program to reduce the risk of fetal exposure to isotretinoin,...
FDA Medwatch Alert: Accutane and generic isotretinoin - Oct 6, 2006
[Posted 10/06/2006] FDA and the iPLEDGE program notified healthcare professionals and patients of an update to iPLEDGE, a risk management program to reduce the risk of fetal exposure to isotretinoin,...
FDA Medwatch Alert: Accutane and generic isotretinoin - Aug 12, 2005
[Posted 08/12/2005] FDA notified healthcare professionals and patients of the approval of a strengthened risk management program, called iPLEDGE, for Accutane and generic isotretinoin. The...
Ask a question
To post your own question to this support group, sign in or create an account.